Oral immunotherapy with omalizumab in patients with severe persistent allergy to cow's milk proteins

被引：0
|
作者：
Penalver Hernandez, M. J. [1 ]
Moya, B. [1 ]
Marin, L. [1 ]
Crespo, J. F. [1 ]
Dieguez, M. C. [1 ]
机构：
[1] Hosp Univ 12 Octubre, Dept Allergy, Madrid, Spain
来源：
ALLERGY | 2020年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0619
引用
收藏
页码：524 / 524
页数：1
相关论文
共 50 条
  • [41] Benefits of baked milk oral immunotherapy in French children with cow's milk allergy
    Gruzelle, Vianney
    Juchet, Agnes
    Martin-Blondel, Audrey
    Michelet, Marine
    Chabbert-Broue, Anne
    Didier, Alain
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2020, 31 (04) : 364 - 370
  • [42] Severe cow's milk allergy
    Shaoul, R
    Mesner, O
    Kessel, A
    Jaffe, M
    ALLERGY, 2002, 57 (10) : 962 - 963
  • [43] Omalizumab for patients refractory to milk oral immunotherapy
    Demir, E.
    Akarcan, Eren S.
    Gunaydin, Cigerci N.
    Severcan, Ulusoy E.
    Ozturk, Kartal G.
    Eski, A.
    Gulen, F.
    ALLERGY, 2018, 73 : 501 - 501
  • [44] Persistent severe cow's milk protein allergy secondary to skin contact
    Wong, SL
    Nayak, AS
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S194 - S195
  • [45] Rate Of Anaphylaxis Caused By Oral Immunotherapy In Children With Cow's Milk Allergy
    Pajno, Giovanni B.
    Crisafulli, Giuseppe
    Salzano, Giuseppina
    Vadala, Roberta
    Arasi, Stefania
    Barberi, Salvatore
    Caminiti, Lucia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB106 - AB106
  • [46] Milk ladder versus early oral immunotherapy in infants with cow's milk protein allergy
    Matsumoto, Yurika
    Fujita, Mayumi
    Ayumi, Tsukahara
    Takamasu, Tetsuya
    Inuo, Chisato
    CLINICAL AND TRANSLATIONAL ALLERGY, 2024, 14 (08)
  • [47] A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy
    Wood, Robert A.
    Kim, Jennifer S.
    Lindblad, Robert
    Nadeau, Kari
    Henning, Alice K.
    Dawson, Peter
    Plaut, Marshall
    Sampson, Hugh A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (04) : 1103 - +
  • [48] Results of tretament of XOLAIR® (omalizumab) associated with oral immunotherapy of cow's milk in anfilactic patient
    Candon Morillo, R.
    Burgos Montero, A. M.
    Moreno Mata, E.
    Ruiz Leon, M. B.
    Gonzalez Sanchez, L. A.
    ALLERGY, 2014, 69 : 537 - 537
  • [49] Clinical and laboratory 2-year outcome of oral immunotherapy in patients with cow's milk allergy
    Elizur, A.
    Appel, M. Y.
    Goldberg, M. R.
    Yichie, T.
    Levy, M. B.
    Nachshon, L.
    Katz, Y.
    ALLERGY, 2016, 71 (02) : 275 - 278
  • [50] When and how to end treatment with Omalizumab while introducing cow's milk and egg double oral immunotherapy in severe allergies
    Barato, D.
    Alba, J. C.
    ALLERGY, 2015, 70 : 610 - 610
12345